Compare SHBI & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SHBI | NPCE |
|---|---|---|
| Founded | 1876 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 636.2M | 623.0M |
| IPO Year | 1997 | 2021 |
| Metric | SHBI | NPCE |
|---|---|---|
| Price | $19.08 | $15.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $19.17 | $18.33 |
| AVG Volume (30 Days) | 180.0K | ★ 196.7K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.51% | N/A |
| EPS Growth | ★ 34.85 | 29.03 |
| EPS | ★ 0.51 | N/A |
| Revenue | $20,853,000.00 | ★ $99,986,000.00 |
| Revenue This Year | $8.97 | $0.90 |
| Revenue Next Year | $6.26 | $24.46 |
| P/E Ratio | $38.06 | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $14.15 | $7.56 |
| 52 Week High | $20.68 | $19.60 |
| Indicator | SHBI | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 46.13 | 41.67 |
| Support Level | $18.88 | $12.52 |
| Resistance Level | $19.31 | $17.04 |
| Average True Range (ATR) | 0.47 | 1.17 |
| MACD | -0.06 | -0.34 |
| Stochastic Oscillator | 9.80 | 24.54 |
Shore Bancshares Inc is a financial holding company based in the United States. Through its subsidiaries, it provides consumer and commercial banking products and services, as well as secondary mortgage lending, trust, wealth management, and financial planning services. The group caters to both business and individual clients, offering checking, savings, certificates of deposit, and overnight investment sweep accounts; commercial lending services, including secured and unsecured loans, working capital loans, lines of credit, etc; and safe deposit boxes, debit cards, telephone banking, and other financial products and services.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.